Diabetic cardiomyopathy is a critical diabetes-mediated co-morbidity characterized by
cardiac dysfunction and heart failure, without predisposing hypertensive or atherosclerotic …

Remote ischemic conditioning (RIC), which involves a series of short cycles of ischemia in
an organ remote to the brain (typically the limbs), has been shown to protect the ischemic …

Metformin is a synthetic biguanide used as an antidiabetic drug in type 2 diabetes mellitus,
achieved by studying the bioactive metabolites of Galega officinalis L. It is also used off-label …

Background and aims Among anti-diabetic medications, metformin has been proven to be
the preferred initial pharmacologic agent for type 2 diabetes mellitus (T2DM) treatment …

Objectives Metformin is an antidiabetic agent that is used as the first-line treatment of type 2
diabetes mellitus. Gallic acid is a type of phenolic acid that has been shown to be a potential …

Type 2 diabetes mellitus (T2DM) is one of the world's leading causes of death and life-
threatening conditions. Therefore, we review the complex vicious circle of causes …

Metabolic landscape and sensitivity to apoptosis induction play a crucial role in acute
myeloid leukemia (AML) resistance. Therefore, we investigated the effect of metformin, a …

Phyllanthus emblica L is a promising medicinal plant for antidiabetic therapy but current
research has not explored its stem bark potential as an antidiabetic agent despite the fact …

Purpose The current umbrella review aimed to evaluate the effect of metformin on all-cause
mortality (ACM), cardiovascular mortality, and cardiovascular disease (CVD) incidence in …

The risk of malignant brain tumors associated with metformin use has rarely been
investigated in humans. This retrospective cohort study investigated such an association …